All-trans retinoic acid and interferon-α increase CD38 expression on adult T-cell leukemia cells and sensitize them to T cells bearing anti-CD38 chimeric antigen receptors

被引：15
作者：
Mihara, K. [1 ]
Yoshida, T. [1 ]
Ishida, S. [1 ]
Takei, Y. [2 ]
Kitanaka, A. [3 ]
Shimoda, K. [3 ]
Morishita, K. [4 ]
Takihara, Y. [5 ]
Ichinohe, T. [1 ]
机构：
[1] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Hematol & Oncol, Hiroshima, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Biochem, Nagoya, Aichi 4648601, Japan
[3] Miyazaki Univ, Fac Med, Dept Internal Med, Div Gastroenterol & Hematol, Miyazaki, Japan
[4] Miyazaki Univ, Div Tumor & Cellular Biochem, Dept Med Sci, Fac Med, Miyazaki, Japan
[5] Hiroshima Univ, Dept Stem Cell Biol, Res Inst Radiat Biol & Med, Hiroshima, Japan
来源：
BLOOD CANCER JOURNAL | 2016年 / 6卷
关键词：
NON-HODGKIN-LYMPHOMA; MYELOMA CELLS; IMMUNOTHERAPY; LEUKEMIA/LYMPHOMA;
D O I：
10.1038/bcj.2016.30
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：e421 / e421
页数：4
相关论文
共 15 条
  • [1] Meta-Analysis on the Use of Zidovudine and Interferon-Alfa in Adult T-Cell Leukemia/Lymphoma Showing Improved Survival in the Leukemic Subtypes
    Bazarbachi, Ali
    Plumelle, Yves
    Ramos, Juan Carlos
    Tortevoye, Patricia
    Otrock, Zaher
    Taylor, Graham
    Gessain, Antoine
    Harrington, William
    Panelatti, Gerard
    Hermine, Olivier
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (27) : 4177 - 4183
  • [2] CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
    Brentjens, Renier J.
    Davila, Marco L.
    Riviere, Isabelle
    Park, Jae
    Wang, Xiuyan
    Cowell, Lindsay G.
    Bartido, Shirley
    Stefanski, Jolanta
    Taylor, Clare
    Olszewska, Malgorzata
    Borquez-Ojeda, Oriana
    Qu, Jinrong
    Wasielewska, Teresa
    He, Qing
    Bernal, Yvette
    Rijo, Ivelise V.
    Hedvat, Cyrus
    Kobos, Rachel
    Curran, Kevin
    Steinherz, Peter
    Jurcic, Joseph
    Rosenblat, Todd
    Maslak, Peter
    Frattini, Mark
    Sadelain, Michel
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (177)
  • [3] Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
    Brentjens, Renier J.
    Riviere, Isabelle
    Park, Jae H.
    Davila, Marco L.
    Wang, Xiuyan
    Stefanski, Jolanta
    Taylor, Clare
    Yeh, Raymond
    Bartido, Shirley
    Borquez-Ojeda, Oriana
    Olszewska, Malgorzata
    Bernal, Yvette
    Pegram, Hollie
    Przybylowski, Mark
    Hollyman, Daniel
    Usachenko, Yelena
    Pirraglia, Domenick
    Hosey, James
    Santos, Elmer
    Halton, Elizabeth
    Maslak, Peter
    Scheinberg, David
    Jurcic, Joseph
    Heaney, Mark
    Heller, Glenn
    Frattini, Mark
    Sadelain, Michel
    [J]. BLOOD, 2011, 118 (18) : 4817 - 4828
  • [4] Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study
    Cruz, Conrad Russell Y.
    Micklethwaite, Kenneth P.
    Savoldo, Barbara
    Ramos, Carlos A.
    Lam, Sharon
    Ku, Stephanie
    Diouf, Oumar
    Liu, Enli
    Barrett, A. John
    Ito, Sawa
    Shpall, Elizabeth J.
    Krance, Robert A.
    Kamble, Rammurti T.
    Carrum, George
    Hosing, Chitra M.
    Gee, Adrian P.
    Mei, Zhuyong
    Grilley, Bambi J.
    Heslop, Helen E.
    Rooney, Cliona M.
    Brenner, Malcolm K.
    Bollard, Catherine M.
    Dotti, Gianpietro
    [J]. BLOOD, 2013, 122 (17) : 2965 - 2973
  • [5] RAPID INDUCTION OF CD38 ANTIGEN ON MYELOID-LEUKEMIA CELLS BY ALL-TRANS-RETINOIC ACID
    DRACH, J
    ZHAO, SR
    MALAVASI, F
    MEHTA, K
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 195 (02) : 545 - 550
  • [6] Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia
    Grupp, Stephan A.
    Kalos, Michael
    Barrett, David
    Aplenc, Richard
    Porter, David L.
    Rheingold, Susan R.
    Teachey, David T.
    Chew, Anne
    Hauck, Bernd
    Wright, J. Fraser
    Milone, Michael C.
    Levine, Bruce L.
    June, Carl H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (16) : 1509 - 1518
  • [7] B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells
    Kochenderfer, James N.
    Dudley, Mark E.
    Feldman, Steven A.
    Wilson, Wyndham H.
    Spaner, David E.
    Maric, Irina
    Stetler-Stevenson, Maryalice
    Phan, Giao Q.
    Hughes, Marybeth S.
    Sherry, Richard M.
    Yang, James C.
    Kammula, Udai S.
    Devillier, Laura
    Carpenter, Robert
    Nathan, Debbie-Ann N.
    Morgan, Richard A.
    Laurencot, Carolyn
    Rosenberg, Steven A.
    [J]. BLOOD, 2012, 119 (12) : 2709 - 2720
  • [8] T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells
    Mihara, K.
    Bhattacharyya, J.
    Kitanaka, A.
    Yanagihara, K.
    Kubo, T.
    Takei, Y.
    Asaoku, H.
    Takihara, Y.
    Kimura, A.
    [J]. LEUKEMIA, 2012, 26 (02) : 365 - 367
  • [9] Synergistic and persistent effect of T-cell immunotherapy with anti-CD19 or anti-CD38 chimeric receptor in conjunction with rituximab on B-cell non-Hodgkin lymphoma
    Mihara, Keichiro
    Yanagihara, Kazuyoshi
    Takigahira, Misato
    Kitanaka, Akira
    Imai, Chihaya
    Bhattacharyya, Joyeeta
    Kubo, Takanori
    Takei, Yoshifumi
    Yasunaga, Shin'ichiro
    Takihara, Yoshihiro
    Kimura, Akiro
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2010, 151 (01) : 37 - 46
  • [10] Activated T-cell-mediated Immunotherapy With a Chimeric Receptor Against CD38 in B-cell Non-Hodgkin Lymphoma
    Mihara, Keichiro
    Yanagihara, Kazuyoshi
    Takigahira, Misato
    Imai, Chihaya
    Kitanaka, Akira
    Takihara, Yoshihiro
    Kimura, Akiro
    [J]. JOURNAL OF IMMUNOTHERAPY, 2009, 32 (07) : 737 - 743
12